Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Case Report
2014:80:4;328-330
doi: 10.4103/0378-6323.136898
PMID: 25035358

Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) with unusual manifestations and without detectable autoantibodies

Jimena Sanz-Bueno, Daniella Cullen, Carlos Zarco, Francisco Vanaclocha
 Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain

Correspondence Address:
Jimena Sanz-Bueno
Hospital 12 de Octubre, Avenida de Córdoba s/n, Madrid - 28041
Spain
How to cite this article:
Sanz-Bueno J, Cullen D, Zarco C, Vanaclocha F. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) with unusual manifestations and without detectable autoantibodies. Indian J Dermatol Venereol Leprol 2014;80:328-330
Copyright: (C)2014 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

We describe a patient with paraneoplastic autoimmune multiorgan syndrome (PAMS) secondary to a lymphoblastic T- cell lymphoma who presented with a lichenoid dermatitis and vitiligo, later developing bronchiolitis obliterans and autoimmune hepatitis. Notably, he had no detectable autoantibodies. The development of vitiligo and autoimmune hepatic involvement probably indicate a role for cytotoxic T- cell lymphocytes in the pathogenesis of this syndrome.
Keywords: Autoimmune diseases, paraneoplastic syndromes, precursor T-Cell lymphoblastic leukemia-lymphoma, lichenoid eruptions

INTRODUCTION

Paraneoplastic pemphigus was first described by Anhalt et al., in 1990 [1] as an atypical pemphigus associated with lymphoid neoplasms and characterized by a vesiculobullous eruption mediated by circulating autoantibodies. [2] However, due to the significant phenotypic heterogeneity of the patients reported, some authors have proposed the term paraneoplastic autoimmune multiorgan syndrome (PAMS) to refer to this disease. [3] We report the case of a patient with PAMS secondary to a T-cell lymphoblastic lymphoma presenting with a graft-versus-host disease (GVHD)-like eruption and vitiligo, who developed lung and liver damage.

CASE REPORT

A 23-year-old man with right kidney congenital atresia of the right kidney and Barrett′s esophagus presented with fever, malaise, arthralgia, mouth erosions, and periocular erythematous patches in September 2008. Cutaneous lesions rapidly progressed along the craniocaudal axis affecting up to 90% of the body surface area. During the following months, they progressively acquired a lichenoid appearance. In March 2010, the biopsy of a cervical lymph node revealed a T-cell lymphoblastic lymphoma. Complete remission was achieved in August 2010 after completion of six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone). Chemotherapy had no effect on skin disease which continued progressing. In October 2010, physical examination showed erythematous, scaly, papules and plaques with follicular plugging and a tendency to reticular pattern, palmoplantar involvement, nail pterygium, and loss of several nails. Diffuse alopecia and keratotic scales were noted on the scalp. Severe ulcers in the oral mucosa, conjunctivitis and erosions on the glans penis and secondary paraphimosis were present. Nikolsky′s sign was negative. Moreover, he developed poliosis of the eyebrows, the eyelashes, the hair and the beard, as well as multiple halo nevi [Figure - 1]. Progressive facial changes were noted, resulting in an elderly appearance [Figure - 2]. Several skin biopsies taken throughout the process showed hyperkeratosis with abundant necrotic keratinocytes in all layers of the epidermis, a band-like lympho-histiocytic infiltrate in the papillary dermis and vacuolar degeneration of the basal layer. No immune complex deposition or circulating autoantibodies were detected by direct or indirect immunofluorescence, respectively. Antibodies against periplakin, envoplakin, and both desmoglein 1 and 3 were negative. As high doses of oral steroids for long periods resulted only in a very slight improvement, cyclosporine was started at doses of 5 mg/kg/day. Two months later, the patient was admitted to the intensive care unit for fever and respiratory failure. Transbronchial biopsy revealed findings that were characteristic for bronchiolitis obliterans. Therapy with prednisone at doses of 1 mg/kg/day and monthly intravenous infusion of high-dose gamma globulin was required during the two months of hospitalization. In June 2011, he developed liver function impairment with a cytolytic pattern (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) >1,000 UI/mL). Liver biopsy showed centrilobular necrosis with replacement of hepatocytes by lymphocytes and macrophages. These findings were strongly suggestive of autoimmune hepatitis, the resolution of which required high doses of prednisone (1 mg/kg/day) for one month. Currently, although no new signs of extracutaneous involvement are present and partial hair repigmentation and growth have been observed, an extensive lichenoid eruption involving almost the entire body persists, despite maintenance therapy with cyclosporine at doses of 3 mg/kg/day.

Figure 1: (a) Erythematous-violaceous lichenoid papules over the trunk and the arms. (b) Scaly plaques, vitiligo, and halo nevi. (c) Onycholysis. (d) Erosions on the glans penis and secondary paraphimosis. (e) Ulcers on the tongue
Figure 2: (a) Seborrheic dermatitis-like patches and lip erosions in September 2008. (b) Facial erythematous plaques, poliosis, and elderly appearance in October 2010

DISCUSSION

Paraneoplastic autoimmune multiorgan syndrome is defined as a mucocutaneous eruption with a polymorphous presentation that has at least five clinical patterns (pemphigus, pemphigoid, exudative erythema multiforme, GVHD-like, and lichen planus-like), and that is accompanied by pulmonary involvement which is the main cause of death in these patients. [3] It is associated with several malignancies, of which hematologic-related neoplasms are the most frequent (84%) followed by adenocarcinomas and sarcomas. [4] Treatment of the underlying neoplasm is generally not associated with an improvement of the disease. [5] The most sensitive and specific antibodies in this disease are those targeting periplakin and envoplakin. [6] However, as was the case with our patient, Cummins et al., reported four cases of PAMS without autoantibodies. [7] This suggests that pathophysiological mechanisms are not only limited to humoral immunity. PAMS may represent a clinical spectrum in which predominance of humoral immunity would result in a bullous disease, as first described by Anhalt, and, conversely, the eruption may resemble GVHD or lichen planus when cell-mediated immune mechanisms are present, [8] as in this case. In fact, the development of vitiligo in our patient may support the theory of cell cytotoxicity. In contrast to bronchiolitis obliterans, autoimmune hepatitis has not been previously documented to be associated with PAMS. Our patient presented with unusual histological findings outside the context of a liver graft. This fact led us to think that, given that our patient had a healthy twin, and transplacental transfusions have been reported between dizygotic dichorionic twins, [9] a hypothetic lymphocyte population derived from his brother may had generated a GVHD-like reaction. However, the molecular analysis of the patient′s damaged skin and peripheral blood by polymerase chain reaction (PCR) failed to show mixed chimerism, rendering this possibility implausible. In sum, the aforementioned patient developed PAMS secondary to T-cell lymphoma with extensive mucocutaneous disease, vitiligo, elderly appearance, and autoimmune damage to the lung and liver. In spite of this dramatic clinical presentation and in contrast to most reports, he is still alive more than four 4 years after the diagnosis was made.

ACKNOWLEDGMENTS

We thank Dr. T. Hashimoto (Kurume University School of Medicine, Japan) for his help with immunofluorescence studies.

References
1.
Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3 rd , Mutasim D, Ariss-Abdo L, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990 Dec 20; 323:1729-35.
[Google Scholar]
2.
Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol. 1997; 12:77-96.
[Google Scholar]
3.
Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando S et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001 Feb;137:193-206.
[Google Scholar]
4.
Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004; 40:553-562.
[Google Scholar]
5.
Zhang J, Qiao QL, Chen XX, Liu P, Qiu JX, Zhao H, Zhao JX, Liu YC, Wan YL, et al. Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: A single-center experience of 22 cases. J Cancer Res Clin Oncol. 2011 Feb; 137:229-34.
[Google Scholar]
6.
Probst C, Schlumberger W, Stöcker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L et al. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 2009;410:13-18.
[Google Scholar]
7.
Cummins DL, Mimouni D, Tzu J, Owens N, Anhalt GJ, Meyerle JH. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 2007; 56:153-159.
[Google Scholar]
8.
Czernik A, Camilleri M, Pittelkow MR, Grando SA. Paraneoplastic autoimmune multiorgan syndrome: 20 years after. Int J Dermatol. 2011;50:905-914.
[Google Scholar]
9.
Jang JH, Jung H, Kim JH, Park WS, Kim SH. Blood chimerism in a dizygotic dichorionic pregnancy. Korean J Lab Med 2010;30:521-4.
[Google Scholar]

Fulltext Views
517

PDF downloads
255
Show Sections